We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 2,156 results
  1. An insight into thymidylate synthase inhibitor as anticancer agents: an explicative review

    Cancer, a widespread challenge to global health, remains a puzzle of intricate molecular dynamics. This review article delves into the mystery of...

    Aratrika Sen, Dipanjan Karati in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 06 March 2024
  2. Development and validation a radiomics nomogram for predicting thymidylate synthase status in hepatocellular carcinoma based on Gd-DTPA contrast enhanced MRI

    Objectives

    The purpose of this study was to develop and validate a radiomics nomogram for predicting thymidylate synthase (TYMS) status in...

    Zongren Ding, Yijun Wu, ... Yongyi Zeng in BMC Cancer
    Article Open access 17 October 2023
  3. MALAT1-miRNAs network regulate thymidylate synthase and affect 5FU-based chemotherapy

    Background

    The active metabolite of 5-Fluorouracil (5FU), used in the treatment of several types of cancer, acts by inhibiting the thymidylate...

    Janusz Matuszyk in Molecular Medicine
    Article Open access 03 August 2022
  4. The Association Between Thymidylate Synthase Gene Polymorphisms and the Risk of Ischemic Stroke in Chinese Han Population

    Family history of hypertension, smoking, diabetes and alcohol consumption and atherosclerotic plaque were identified as common risk factors in IS. We...

    Fuhua Yu, Lei Shi, ... Yilei **ao in Biochemical Genetics
    Article Open access 28 June 2023
  5. A phase I open-label, dose-escalation study of NUC-3373, a targeted thymidylate synthase inhibitor, in patients with advanced cancer (NuTide:301)

    Purpose

    5-fluorouracil (5-FU) is inefficiently converted to the active anti-cancer metabolite, fluorodeoxyuridine-monophosphate (FUDR-MP), is...

    Pavlina Spiliopoulou, Farasat Kazmi, ... Sarah P. Blagden in Journal of Experimental & Clinical Cancer Research
    Article Open access 02 April 2024
  6. A possible link to uracil DNA glycosylase in the synergistic action of HDAC inhibitors and thymidylate synthase inhibitors

    It is well established that thymidylate synthase inhibitors can cause cellular toxicity through uracil DNA glycosylase (UNG2)-dependent pathways....

    Meredith S. Showler, Brian P. Weiser in Journal of Translational Medicine
    Article Open access 07 October 2020
  7. Thymidylate synthase drives the phenotypes of epithelial-to-mesenchymal transition in non-small cell lung cancer

    Background

    Epithelial-to-mesenchymal transition (EMT) enhances motility, stemness, chemoresistance and metastasis. Little is known about how various...

    Mohammad Aarif Siddiqui, Paradesi Naidu Gollavilli, ... Paolo Ceppi in British Journal of Cancer
    Article Open access 07 October 2020
  8. Differential expression of enzymes in thymidylate biosynthesis in zebrafish at different developmental stages: implications for dtymk mutation-caused neurodegenerative disorders

    Background

    Deoxythymidine triphosphate (dTTP) is an essential building block of DNA, and defects in enzymes involved in dTTP synthesis cause...

    Junmei Hu Frisk, Stefan Örn, ... Liya Wang in BMC Neuroscience
    Article Open access 27 March 2022
  9. 3’UTR polymorphism of Thymidylate Synthase gene increased the risk of persistence of pre-neoplastic cervical lesions

    Background

    Cervical cancer is caused by high-risk Human Papillomavirus (hr-HPV) infection associated with cofactors that has been analyzed as...

    Nayara Nascimento Toledo Silva, Ana Carolina Silva Santos, ... Angélica Alves Lima in BMC Cancer
    Article Open access 15 April 2020
  10. Uricase sensitizes hepatocellular carcinoma cells to 5-fluorouracil through uricase-uric acid-UMP synthase axis

    Conventional chemotherapy plays a key role in hepatocellular carcinoma (HCC) treatment, however, with intrinsic or acquired chemoresistance being a...

    Saihong Yu, Zhuduo Li, ... Jie Yu in Journal of Physiology and Biochemistry
    Article 08 June 2022
  11. Enzyme kinetics of deoxyuridine triphosphatase from Western corn rootworm

    Objective

    The Western corn rootworm (WCR), Diabrotica virgifera virgifera , is a highly adaptable insect pest that has evolved resistance to a variety...

    Carlos Riera-Ruiz, Hideaki Moriyama in BMC Research Notes
    Article Open access 16 November 2023
  12. Challenges and Future of Cancer Pharmacogenetics

    Pharmacogenetics is the study of genetic differences in the location and effect of drugs in different population in order to select the optimal drug...
    Gurfateh Singh, Ramica Sharma, ... Mohanbir Singh in Handbook of Oncobiology: From Basic to Clinical Sciences
    Reference work entry 2024
  13. Raltitrexed regulates proliferation and apoptosis of HGC-27 cells by upregulating RSK4

    Background

    Raltitrexed is a specific inhibitor of thymidylate synthase and a potential chemotherapeutic agent for the treatment of advanced gastric...

    Cong Hu, **nhua Chen, ... Jiang Yu in BMC Pharmacology and Toxicology
    Article Open access 28 August 2022
  14. In silico bioprospecting of receptors for Doderlin: an antimicrobial peptide isolated from Lactobacillus acidophilus

    The emergence of resistant bacteria strains against traditional antibiotics and treatments increases each year. Doderlin is a cationic and...

    Elias Jorge Muniz Seif, Marcelo Yudi Icimoto, Pedro Ismael da Silva Junior in In Silico Pharmacology
    Article 25 April 2023
  15. Cytotoxic Cancer Drugs

    Chemotherapy is one of the pillars of cancer treatment, with first reports of its use dating back hundreds of years. Cytotoxic drugs damage malignant...
    Ali Nowroozi, Nima Rezaei in Handbook of Cancer and Immunology
    Living reference work entry 2023
  16. Challenges and Future of Cancer Pharmacogenetics

    Pharmacogenetics is the study of genetic differences in the location and effect of drugs in different population in order to select the optimal drug...
    Gurfateh Singh, Ramica Sharma, ... Mohanbir Singh in Handbook of Oncobiology: From Basic to Clinical Sciences
    Living reference work entry 2023
  17. FOXM1-induced TYMS upregulation promotes the progression of hepatocellular carcinoma

    Background

    Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer and one of the major causes of cancer-related death....

    Liang Wang, Caiyan Shi, ... Yilin Xu in Cancer Cell International
    Article Open access 29 January 2022
  18. Thymidine nucleotide metabolism controls human telomere length

    Telomere length in humans is associated with lifespan and severe diseases, yet the genetic determinants of telomere length remain incompletely...

    William Mannherz, Suneet Agarwal in Nature Genetics
    Article 23 March 2023
  19. Curcumin-Loaded Chitosan-Coated 5-Fluorouracil Encapsulated Nanozeolitic Imidazolate Framework for Combination Cancer Therapy

    Background

    5-Fluorouracil (5-FU) is a good anti-cancer drug, but its prolonged use results in overexpression of certain enzymes like thymidylate...

    Jiju Kazhani Radhakrishnan, Subhadra Suma, ... Reshmi Ramachandran in Journal of Pharmaceutical Innovation
    Article 19 September 2023
  20. Emerging Pathophysiology and Treatment of Prostate Cancer: Future Perspective

    There is wide variability in the response of individuals to standard doses of drug therapy. This is an important problem in clinical practice, where...
    Rahul Rawat, Mini Dahiya, ... Pratibha Dhakla in Handbook of Oncobiology: From Basic to Clinical Sciences
    Reference work entry 2024
Did you find what you were looking for? Share feedback.